RVPH
Reviva Pharmaceuticals Holdings, Inc.
0.66
7072 x 0.66
1000 x 0.68
bid
ask
+
0.01
1.49%
10:00 AM
timesize
| Ytd | -88.18% | |
| 1y | -91.07% |
0.66
day range
0.66
0.26
52 week range
17.20
| Open | 0.66 | Prev Close | 0.65 | Low | 0.66 | High | 0.66 | Mkt Cap | 8.65M |
| Vol | 1.43K | Avg Vol | 500.30K | EPS | -3.33 | P/E | N/A | Forward P/E | -2.02 |
| Beta | -0.06 | Short Ratio | 19.04 | Inst. Own | 30.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.65 | 200-d Avg | 5.47 | 1yr Est | 14.80 |
| Income Statement | |||
| Operating Expenses | 3.27M | ||
| Research and Development Expense | 1.44M | ||
| Selling, General and Administrative Expense | 1.84M | ||
| Operating Income | -3.27M | ||
| Interest Expense | 6.65K | ||
| Income Tax Expense | 3.35K | ||
| Net Income | -3.20M | ||
| Net Income Common Stock | -3.20M | ||
| Net Income Common Stock (USD) | -3.20M | ||
| Consolidated Income | -3.20M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | -3.19M | ||
| Earning Before Interest & Taxes (USD) | -3.19M | ||
| Weighted Average Shares | 7.02M | ||
| Weighted Average Shares Diluted | 7.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.19M | ||
| Cash and Equivalents (USD) | 22.19M | ||
| Current Assets | 23.56M | ||
| Total Assets | 23.56M | ||
| Debt Current | 231.27K | ||
| Total Debt | 231.27K | ||
| Current Liabilities | 6.12M | ||
| Total Liabilities | 6.12M | ||
| Accumulated Retained Earnings (Deficit) | -187.33M | ||
| Shareholders Equity | 17.44M | ||
| Shareholders Equity (USD) | 17.44M | ||
| Total Debt (USD) | 231.27K | ||
| Trade and Non-Trade Payables | 2.09M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 11.55M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.75M | ||
| Issuance (Purchase) of Equity Shares | 11.73M | ||
| Issuance (Repayment) of Debt Securities | -175.60K | ||
| Net Cash Flow from Operations | -3.80M | ||
| Share Based Compensation | 584.44K | ||